WILLS EYE RESEARCH NEWS
In the News
Clinical trial shows potential for treating glaucoma and diabetic retinopathy

In the News
Rapid Developments in Geographic Atrophy

Research News
Allen Ho, MD named to Nanoscope Therapeutics Visionary Advisory Committee

In the News
Optogenetics for retinal disease

Research News
Next-generation treatments for retinal disease

Research News
Effect on vision of GLP-1 drugs on older adults with diabetes

Research News
Clinical trial results for treatment of non-proliferative diabetic retinopathy

In the News
FLIO: an emerging imaging modality for ophthalmic and neurologic pathologies

In the News
Recap of Dr. Joel Schuman's Presentation at 2025 American Glaucoma Society Meeting

In the News
Insights on VERONA Clinical Trial of EYP-1901

In the News
Wills Eye at ARVO 2025
In the News
Second-Generation Anti-VEGFs in Age-Related Macular Degeneration

In the News
Electrical Stimulation Therapy: A Promising Approach to Vision Loss in Glaucoma and Other Optic Neuropathies
In the News
CVI a leading cause of visual impairment in children but often overlooked

In the News
Phase 2 DAVIO 2 Clinical Trial Results

In the News
Impact of Prior DME Treatment on Aflibercept 8 mg Outcomes
In the News
Video: Diabetic Macular Edema Study Results

Press Release
WILLS EYE GLAUCOMA LEADER RECEIVES $6.2 MILLION NIH AWARD FOR VISION RESEARCH

In the News
New Gene Therapy for Retinitis Pigmentosa Shows Promise

In the News
Wills to Present Study Results that Aid Detection of ATTR

Press Release
STUDY RESULTS ON ENDOPHTHALMITIS RATES AND TYPES OF TREATMENTS AFTER INTRAOCULAR PROCEDURES
In the News
Treating Wet AMD Patients Who Also Have Geographic Atrophy

In the News
Wills Study: Post-op Endophthalmitis Rates Down Fourfold Over 20-Year Period

In the News
Wills Residents Offer Strategies for AI in Healthcare